Praxis Investment Management Inc. trimmed its holdings in shares of Veeva Systems Inc. (NYSE:VEEV – Free Report) by 20.4% in the first quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 3,090 shares of the technology company’s stock after selling 790 shares during the quarter. Praxis Investment Management Inc.’s holdings in Veeva Systems were worth $716,000 as of its most recent filing with the SEC.
Other hedge funds have also recently bought and sold shares of the company. Leigh Baldwin & CO. LLC acquired a new stake in shares of Veeva Systems during the fourth quarter worth $685,355,000. Norges Bank acquired a new stake in shares of Veeva Systems in the 4th quarter valued at about $294,785,000. Wealthfront Advisers LLC lifted its holdings in shares of Veeva Systems by 29,760.5% in the fourth quarter. Wealthfront Advisers LLC now owns 1,048,700 shares of the technology company’s stock valued at $220,489,000 after purchasing an additional 1,045,188 shares in the last quarter. Stockbridge Partners LLC bought a new stake in shares of Veeva Systems in the fourth quarter valued at about $137,260,000. Finally, Marshall Wace LLP boosted its position in shares of Veeva Systems by 413.3% during the fourth quarter. Marshall Wace LLP now owns 638,380 shares of the technology company’s stock worth $134,219,000 after buying an additional 514,004 shares during the period. 88.20% of the stock is currently owned by institutional investors and hedge funds.
Insider Buying and Selling at Veeva Systems
In related news, insider Thomas D. Schwenger sold 1,200 shares of the company’s stock in a transaction dated Monday, April 14th. The shares were sold at an average price of $220.97, for a total value of $265,164.00. Following the transaction, the insider now directly owns 25,889 shares in the company, valued at approximately $5,720,692.33. This represents a 4.43% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Timothy S. Cabral sold 315 shares of the firm’s stock in a transaction dated Friday, June 6th. The stock was sold at an average price of $289.72, for a total transaction of $91,261.80. Following the transaction, the director now directly owns 5,500 shares in the company, valued at approximately $1,593,460. This represents a 5.42% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 6,184 shares of company stock valued at $1,376,179 in the last three months. 10.30% of the stock is currently owned by company insiders.
Analyst Upgrades and Downgrades
View Our Latest Analysis on Veeva Systems
Veeva Systems Trading Down 0.8%
VEEV opened at $279.28 on Friday. The stock’s fifty day simple moving average is $248.97 and its 200 day simple moving average is $234.17. Veeva Systems Inc. has a 1-year low of $177.41 and a 1-year high of $291.69. The stock has a market cap of $45.64 billion, a PE ratio of 59.17, a price-to-earnings-growth ratio of 2.20 and a beta of 0.99.
Veeva Systems (NYSE:VEEV – Get Free Report) last issued its quarterly earnings data on Wednesday, May 28th. The technology company reported $1.97 earnings per share for the quarter, beating the consensus estimate of $1.74 by $0.23. The company had revenue of $759.04 million for the quarter, compared to analyst estimates of $728.38 million. Veeva Systems had a net margin of 27.34% and a return on equity of 13.96%. The company’s revenue was up 16.7% on a year-over-year basis. During the same period in the prior year, the firm earned $1.50 earnings per share. Equities analysts forecast that Veeva Systems Inc. will post 4.35 earnings per share for the current year.
About Veeva Systems
Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.
Further Reading
- Five stocks we like better than Veeva Systems
- Investing in Construction Stocks
- GE Aerospace Turns Engines Into Long-Term Profits
- What is the S&P 500 and How It is Distinct from Other Indexes
- Smith & Wesson Stock Falls on Earnings Miss, Tariff Woes
- Dividend Payout Ratio Calculator
- Marvell’s New AI Chip Deals Capture Wall Street’s Attention
Want to see what other hedge funds are holding VEEV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Veeva Systems Inc. (NYSE:VEEV – Free Report).
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.